High-throughput drug screening allowed identification of entry inhibitors specifically targeting different routes of SARS-CoV-2 Delta and Omicron/BA.1.

Kuzikov M, Woens J, Zaliani A, Hambach J, Eden T, Fehse B, Ellinger B, Riecken K
Biomed Pharmacother. 2022 Jul;151:113104. doi: 10.1016/j.biopha.2022.113104. Epub 2022 May 16. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.